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The genome represents much more than a passive library of genetic information. It functions as an information-retrieval device instructed to dynamically change conformation to 
expose the genetic information required for a particular cell type 
under a particular cellular situation. It is now thought that dis-
tinct changes in the three-dimensional (3D) arrangement of our 
(epi)genomes occur in association with development, physiologi-
cal responses, aging, response to diet, environmental stress and/or 
learning. Just as a map of the world is more than a list of places 
and street names, the nuclear genome is more than a string of let-
ters and can be described as a complex choreography of proteins 
and nucleic acids that interact differentially over time. How these 
complex DNA-based functions are achieved within the constrained 
nuclear space, and how the chromatin context of any given gene is 
regulated, remained elusive until 

recently.



New technologies are paving the way for exploration of the struc-
ture and dynamics of chromatin1,2, and future developments integrat-
ing different approaches offer further promises. Indeed, we now face 
the great challenge of taking the linear genome sequence provided by 
the Human Genome Project3,4, decorated with the valuable annota-
tions provided by the ENCODE, Roadmap and FANTOM projects, 
among others5, and creating an integrated 4D understanding of the 
complexity of the cell nucleus. Given the remarkable technologies 
Q2Q3 Q4 Q5 6
and data sets now available, it is time to launch a concerted effort 
toward characterizing the dynamic organization of the genome and 
the rules that govern determination and maintenance of cell types 
(see, for example, recent complementary initiatives in US, NIH-
4DNucleome6; Europe, EU-4DNucleome and LifeTime; and Japan, 
Japan-4DNucleome). We envisage a complete 3D atlas in time (4D) 
of nuclei within the thousands of cell types that form an organism.
The 4D nucleome is a rapidly evolving field that has been expo-
nentially growing since the 1980s, just as the protein structure field 
exploded in the 1960s once the first structures of proteins emerged. 
The establishment of the Protein Data Bank (PDB)7 and its associ-
ated structural format was instrumental for the sharing of informa-
tion, allowing structural data to revolutionize biochemistry, protein 
engineering approaches and drug design. However, as huge amounts 
of structural information accumulated, it became clear that to maxi-
mize the utility and reliability of the structural models, standardized 
and validated pipelines for data processing were needed, and the 
massive storage of standardized data sets were required in addition 
to mere 3D coordinates. First the X-ray crystallography commu-
nity8,9, and later other groups10,11, decided to address this challenge, 
and the PDB has been evolving toward a standardized, validated 
metadata repository. The 4D nucleome community is at a turning 
point and must now address a similar challenge.
Challenges and guidelines toward 4D nucleome 
data and model standards
Marc A. Marti-Renom   1,2,3*, Genevieve Almouzni4, Wendy A. Bickmore   5, Kerstin Bystricky 
 6, Giacomo Cavalli   7, Peter Fraser   8,9, Susan M. Gasser10,11, Luca Giorgetti10, Edith Heard12, 
Mario Nicodemi13,14, Marcelo Nollmann   15, Modesto Orozco16,17, Ana Pombo   14,18,19 and Maria-
Elena Torres-Padilla   20,21
Due to recent advances in experimental and theoretical approaches, the dynamic three-dimensional organization (3D) of the 
nucleus has become a very active area of research in life sciences. We now understand that the linear genome is folded in ways 
that may modulate how genes are expressed during the basic functioning of cells. Importantly, it is now possible to build 3D 
models of how the genome folds within the nucleus and changes over time (4D). Because genome folding influences its func-
tion, this opens exciting new possibilities to broaden our understanding of the mechanisms that determine cell fate. However, 
the rapid evolution of methods and the increasing complexity of data can result in ambiguity and reproducibility challenges, 
which may hamper the progress of this field. Here, we describe such challenges ahead and provide guidelines to think about 
strategies for shared standardized validation of experimental 4D nucleome data sets and 

models.Q1
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Assessment of genome and epigenome structural and dynamic 
data from molecular genomics, imaging and computational model-
ing requires agreement on a series of validation pipelines that the 
community should adopt, as well as data sharing strategies and an 
accepted format for depositing the data. This is a nontrivial issue 
given the rapid evolution of technologies, the variety of methods 
used and the intrinsically multidimensional nature of the problem. 
Moreover, proper translation of the data into biological insight with 
subsequent functional validations represents a major challenge. 
Next, we briefly review the state of the art of each of the standard-
ization and validation approaches to study and interpret nuclear 
organization.
Molecular genomics
The 4D nucleome community has developed and implemented 
genomic technologies that allow an integrated investigation of gene 
expression, epigenetic marks, nucleosome localization and genome 
interactions, both for cell populations and at the single-cell level. 
These technologies rely on the use of high-throughput experimental 
approaches and next-generation sequencing (NGS) to characterize 
genome organization and chromatin status at the molecular level. 
Information retrieved from sequencing provides data of protein 
occupancy at specific genomic regions, nucleosome organization, 
DNA methylation and 3D chromatin associations, which enable 
multiresolution information on chromatin structure to be deduced 
and modeled.
For example, nucleosome positioning techniques are based on 
sequencing of chromatin after DNA digestion that treats nucleo-
some-bound compared to unbound (linker) DNA differentially. 
Several technologies have been developed that differ mainly in the 
way DNA is digested or how DNA–protein interactions are iden-
tified12,13. Promoter and enhancer accessibility data are key for 
understanding regulation of gene expression, and assay for trans-
posase-accessible chromatin using sequencing (ATAC)-seq 

has 
emerged as a tool to probe this aspect14. All these approaches pres-
ent challenges that need to be addressed to validate and standard-
ize the resulting data sets, especially for single-cell experiments in 
which the data are sparse and cannot be replicated. For example, 
the data can be noisy, biased by sequence preferences of process-
ing enzymes, cross-linking reagents, antibody specificity, and stan-
dard sequence biases of NGS. Moreover, nucleosomes are sliding 
along the sequence, which means they do not have fixed positions, 
but probability distributions are observed, which require very deep 
sequencing to be reliable. 

Importantly, nucleosome positioning data 
sets almost invariably represent an average map, which has to be 
considered in light of cell-to-cell variability, something that requires 
complex deconvolution of the detected signals into unique nucleo-
some families. Recently, single-cell and single-molecule mapping 
variants of some of these technologies provided an exciting perspec-
tive while raising the challenge of gathering epigenomic maps from 
intrinsically scattered data15–17.
Although these approaches provide a steady state picture of the 
epigenome, an emerging class of time-resolved methods should ulti-
mately enable its dynamic characterization at multiple time scales. 
Indeed, histone dynamics have been studied genome-wide on a time 
scale of minutes18–20. An emerging microfluidics-based methodol-
ogy also allows tracking of site-specific protein–DNA contact kinet-
ics on a time scale of seconds by measuring cross-linking kinetics21. 
Other approaches use fusion constructs to characterize protein 
residence time on DNA, exploiting a time course of MNase diges-
tion22 or the anchor-away system23. Although the diversity of experi-
mental systems provides great promise, comparing these methods 
has proven difficult. The building of integrated models of the 4D 
nucleome should tackle these limitations and solve the problem of 
translating linear nucleosome distributions into time-dependent 3D 
arrangements consistent with time-resolved imaging data.
Q7
Q8
Chromosome conformation capture techniques (3C)24 come 
in various flavors25. These approaches are limited by a number 
of potential issues, including the degree of cross-linker fixation, 
nuclear permeabilization, as well as solubilization, digestion and 
ligation efficiencies. Other more specific issues such as oligonucle-
otide design exist for 5C and capture Hi-C. Data processing and 
bioinformatic analyses of “C” data are complex, and approaches for 
quality control and normalization remain an open challenge. This 
is particularly important given the blooming of experimental varia-
tions on the main technology, each carrying different advantages, 
limitations and potential sources for bias. Common standards do 
not yet exist, which is becoming a major challenge for the ability 
to compare different data sets to obtain meaningful conclusions. 
We need to perform extensive benchmarking of the experimental 
and computational analyses to reach a consensus on standards26. 
Furthermore, validation with independent technologies is needed. 
Direct comparison with data sets from orthogonal approaches, such 
as those from genome architecture mapping (GAM)27, and imaging 
offers great promise toward defining gold standards28–31. Though 
this should mature, newer approaches will continue to emerge. For 
example, in GAM27, C-Walks32 or SPRITE33, more than two chro-
matin contacts can be captured and analyzed. This calls for setting 
up dedicated analytical tools and pipelines and further testing with 
complementary technologies, such as high-throughput microscopy.
Light and electron microscopy
DNA and RNA FISH have long been used to evaluate the loca-
tion and activity of genomic loci and the position of whole chro-
mosomes in situ at the single-cell level. The limitations in spatial 
resolution, throughput, and genomic coverage have been major 
challenges. However, the advent of 3D high-throughput (deep-
imaging) and super-resolution imaging (nanoscopy) technologies 
coupled with novel DNA/RNA labeling strategies are now enabling 
the visualization of genomic domains, individual genes and single 
transcripts in 3D. Novel approaches to tag chromosomal domains 
include multiplexing probes by oligopaints or antibody labeling in 
fixed cells30,34–36. Well-known technologies for live imaging involve 
the use of stem-loop structures in RNAs and fluorescent viral pro-
teins that recognize these tags (MS2/MCP or PP7)37,38, as well as 
bacterial operator arrays that can be visualized by fluorescently 
tagged repressor proteins and other “fluorescent repressor opera-
tor systems” (FROS)39–41. New labeling techniques take advantage of 
protein oligomerization such as Suntag42 or ANCHOR43. The advent 
of CRISPR-inactive Cas9-bound guide RNAs for fluorescently tag-
ging DNA44,45 or transcription activator-like effectors

 (TALE)46,47 is 
changing the landscape of visualization options when fused to fluo-
rescent proteins to enable the visualization of naturally occurring 
repetitive sequences. Each of these systems is likely to have its spe-
cific limitations and may potentially interfere with chromatin biol-
ogy in a context-dependent manner as reported for lacO FROS48 
or CRISPR-based tagging systems49. However, several reports reca-
pitulate the live-cell imaging results (TetO-tagged loci in embry-
onic stem cells) in fixed cells50,51, suggesting that these approaches 
are not generally disruptive of genome architecture and function. 
SNAP- or CLIP-tag technologies52,53 for labeling proteins, fluores-
cent antibody fragments54 and development of new, brighter dyes 
offer seemingly unlimited possibilities to probe nanoscale struc-
tures of chromatin. As these methods rely on fusion proteins (with 
potential hindrance to their function) or antibodies (with poten-
tial specificity issues), integrating results from multiple approaches 
will be critical. Photoactivable or SNAP-tag-based approaches can 
also be used to measure protein dynamics in the nucleus55, together 
with fluorescence recovery after photobleaching (FRAP), fluores-
cence correlation spectroscopy (FCS) and single-molecule track-
ing methods. Analytical methods to integrate data from these 
approaches are a subject of intense research31,35. In the past 10 years, 
Q9
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super-resolution imaging of single molecules has paved the way for 
even an more detailed analysis of chromatin structural variations 
within the nucleus56,57. In particular, it is now possible to beat the 
diffraction limit by a full order of magnitude using stochastic opti-
cal reconstruction microscopy (STORM), photoactivated localiza-
tion microscopy (PALM) and structured illumination microscopy 
(SIM), which can reach 20-nm lateral resolution.
An experimental challenge for single-molecule imaging in live 
nuclei is the need to capture the rapid 3D motion of nuclear fac-
tors (diffusion coefficient ~10 μ m2/s). The recently developed mul-
tifocal microscope (MFM) enables the parallel acquisition of up to 
twenty-five focal planes58,59. One can thus image cellular volumes 
over an axial depth of ~5 μ m, comparable to the size of eukary-
otic nuclei, with acquisition rates of up to hundreds of times faster 
than conventional methods60,61. Standard fluorescence signals can 
now also be captured in thick samples with light-sheet microscopy, 
which, together with aberration-corrected multifocus microscopes, 
will enable time-lapse imaging that is many fold faster and has 
much less bleaching than conventional spinning-disk or wide-field 
fluorescence microscopy58. In fixed cells, chromatin fibers can be 
visualized by chromatin EM tomography62. Combined light micros-
copy–electron microscopy (CLEM) provides locus-specific label-
ing by fluorescence and either conventional EM or serial block face 
scanning electron microscopy ultrastructural information of the 
entire nucleus, cell or tissue. 3D EM can now also be correlated with 
time-lapse fluorescence imaging in living cells63. 

Finally, SBF-EM64 
enables 3D reconstruction of cellular structures at nanometer reso-
lution.
Altogether, it is now clear that chromatin structure is becom-
ing accessible to the microscope on all levels of resolution, as are 
long-range contacts through the 3C technologies. Indeed, light 
imaging has enabled partial validation of “C” data35,65, as the distri-
butions of distances between loci can be measured and chromatin 
domains or TADs mapped using large or multiple probes30,31,35,65. 
Furthermore, FISH or live-cell tagging technologies can be com-
bined with immunofluorescence66 or fluorescent fusion proteins 
for a variety of nuclear bodies and structures51,67–69 to gain insight 
into the chromatin state or nuclear compartment in which a locus 
resides. The most obvious advantage of these imaging approaches 
is that the position and status of a genomic locus can be measured 
in vivo and at the single-cell level in a cell population and in tissue 
sections, preserving cell–cell interactions. The disadvantages still 
remain the number of loci that can be measured at any one time, 
the need to genetically modify, transfect or otherwise treat the cells 
to generate fluorescent signals and the reliance on in vitro mod-
els of cell culture. The controls and standards for these techniques 
remain very different among laboratories. In microscopy, not only 
the experimental conditions but also the instrument itself and the 
image-analysis tools provide a huge number of variables. Standard 
pipelines for quantification of signal adapted to the noise (pixels), 
segmentation procedures and explicit distinction between 2D and 
3D image analysis are, with some exceptions, lacking in the field. 
Finally, an effort must be made to deploy image-analysis codes in 
an open web format.
A final and very real challenge for imaging is performing experi-
ments that are physiologically relevant; that is, finding conditions 
that minimize phototoxicity and potential artifacts of fixation. As 
the biological relevance of any observed event is primordial, it must 
be tracked over multiple conditions, and the statistical analysis 
of many individual event recordings must be considered integral 
to any microscopic approach. In addition to the need for high- 
resolution and rapid time-lapse imaging, we require means of stor-
ing, processing and analyzing the huge imaging data sets, as well as 
analytical tools that extract physical principles from the geometry 
and movement of chromatin. Only then can modeling of particle 
and fiber dynamics be applied to properly interpret the results of 
Q10
moving chromatin loci and integrate them with ‘fixed’ cell imaging 
or population-based molecular analyses.
3D/4D modeling
Theoretical approaches have become key for investigating the com-
plexity of high-throughput 4D nucleome data. Two main approaches 
have been used over the last decades to model chromatin70. First, 
physical modeling, which has its roots in atomistic simulation 
methods, has been used to identify plausible spatial arrangements of 
the chromatin fiber, consistent with the laws of polymer physics. For 
example, these approaches have been implemented to interpret the 
decay of interaction frequencies with the genomic distance71,72, the 
formation of domains of active and inactive chromatin73, the forma-
tion of domains by loop extrusion74, and epigenetic features such 
as chromatin types75, chromosome territories76–78 and co-expres-
sion data79, among others. Furthermore, models have been directly 
compared to experimentally derived interaction data sets to char-
acterize potential molecular mechanisms underlying chromosome 
folding27,74,80–83. Second, the so-called restraint-based modeling has 
more recently been used to represent experimental observations 
from cell populations and single cells as sets of spatial restraints to 
fold the genome in 3D. The main experimental data driving these 
models come from 3C-based experiments, including single-cell 
Hi-C84-86, as well as imaging87.
Independently of the approach used for 3D/4D modeling, vali-
dating the accuracy of the resulting structural models is important 
and challenging. The difficulties arise not only from the diversity 
of chromatin arrangements in the cell population and the limited 
information about the native configuration/organization of the 
genome, but also from the lack of standards for sharing models. 
Currently, there is not a proposed standard for storing the coor-
dinates of the resulting models, for linking the models with the 
experimental data used for its derivation, or for putting them in the 
context of previously known genomic information. More dramati-
cally, no protocol exists to bridge the different levels of resolution on 
genome architecture and allow the final user to navigate from the 
base pair to the nucleosome array up to the global chromatin struc-
ture. Nowadays, each software uses its own formats, which are not 
easy to share, and key data to reproduce the computational experi-
ment are not stored, making reproducibility a big challenge. Only 
recently have a significant number of models of genome organiza-
tion at different levels of resolution been published65,88–94. However, 
those are not centrally deposited, do not share standards and have 
only been partially validated. It is now time to identify guidelines 
for validating, annotating, and depositing 3D/4D genome models at 
all resolutions generated with software that can be easily shared and 
models that can be reproduced, mimicking efforts made by other 
communities. Initial steps toward validation and assessment of the 
resulting structural models are being taken95, including efforts such 
as those implemented in the virtual research environment of the 
Multiscale Complex Genomics Consortium (MuG), and this work 
needs to be continued and generalized in the future.
Experimental systems and functional validation assays
The ultimate validation of the data and models will come from pre-
dictions and their experimental testing by perturbing the biological 
systems of interest96. With the recently extended toolbox and the rise 
of biophysics and computational biology, the characterization of 4D 
genome structure and function is booming. Though technology has 
been an important driver for this progress, answering critical ques-
tions in the field such as how much of the structure dictates function 
and vice versa requires the selection of the appropriate biological 
systems and approaches to dissect the role of putative regulatory 
components. This issue is not novel, and the ENCODE project97 has 
proposed a series of cell lines and tissues that could be used for these 
studies, which are subdivided into tiers 1, 2 and 3 in decreasing 
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order of priority. Tier 1 cell lines have been used extensively to ana-
lyze chromatin contacts98,99, but, to understand functional aspects 
of chromosome architecture dynamics, it is important to analyze 
the temporal order of events using nontransformed cells that can be 
differentiated or stimulated. For this reason, models such as human 
H1 or mouse embryonic stem (ES) cells that allow differentiation 
into several lineages100–103, cell stimulation by hormone treatment104 
or genomic perturbations of key structural proteins105,106 can pro-
vide invaluable information. The collection of dense time series 
will be important for characterizing regulatory and stochastic dif-
ferences over time. Likewise, analyses of multiple interrelated cell 
types along well-characterized differentiation paths, such as in the 
hematopoietic system107, are likely to be instrumental in the elabo-
ration of predictive models. The analysis of carefully controlled cell 
differentiation systems should be complemented by in vivo work 
from sorted cells102, and particularly in the case of humans, a valu-
able alternative is the use of organoids obtained from differentiation 
of ES or iPS cells.
Furthermore, to go beyond correlations, it is important to 
manipulate the genome and uncouple effects on chromosome 
structure from effects on gene expression and DNA replication or 
repair. Multiple approaches are being developed toward this goal. 
In addition to knockdown and CRISPR-mediated gene knockout 
approaches, TALE- and CRISPR-based technology can be used to 
tether regulatory factors to study the effect on their target sites. This 
is true both for activation108 and for repression109. Furthermore, 
recent developments allow multiplexing of these gene regulatory 
approaches110. Another strategy consists in tethering DNA domains 
to nuclear landmarks such as the lamina, which allows testing 
whether ‘geographical’ changes in gene position affect chromo-
some architecture and function111. TALE-based approaches can also 
be used to alter chromatin condensation without affecting tran-
scription to study the effects on nuclear positioning of the cognate 
loci112,113. Moreover, specific mutations can be induced at individual 
sequence elements to study whether changes at a given position in 
the genome can induce long-range effects elsewhere114,115. Finally, 
new predictive models, such as PRISMR, are now able to predict the 
effect of structural variants in the topology of the genome96. Further 
developments of this rich toolbox should allow the performance of 
surgical genome technology experiments that should help research-
ers characterize the role of chromatin components in a quantitative 
way and tease apart correlations from causative roles.
Toward FAiR data, unified standards and RiCH 
visualizations in 4D nucleome research
The quantity and quality of information that is being generated to 
explore and understand the organization, packaging and functions 
of the genome has grown tremendously in recent years, but many of 
these data cannot be fully exploited owing to the lack of standardiza-
tion of procedures, lack of detailed information on various aspects 
of the setup and lack of data formats and visualization. Likewise, 
many current models cannot be used or compared among each 
other. To fully exploit the information that is being generated, both 
at the experimental and at the theoretical level, all these data should 
be made findable, accessible, interoperable and re-usable (FAIR)116. 
Here, we would like to propose good practice guidelines to ensure 
that data follow FAIR principles and to facilitate the implementation 
of common standards, both on the experimental and the modeling 
side (Fig. 1 and Table 1).
Concerning experimental approaches, we propose the follow-
ing recommendations: (i) Data deposition. Deposit data in pub-
lic repositories, providing rich and detailed metadata describing 
the materials, biological samples, experimental conditions and 
protocols. For imaging, the development of public repositories 
is still in discussion and in the testing phase, but it is highly rec-
ommended that primary images with appropriate metadata be 
stored and maintained until public repositories become available 
to the community. (ii) Standards. Use standardized, benchmarked 
experimental protocols for sample preparation and analysis. If the 
approach involves establishing new strategies, accompany new data 
with a standard data set to allow comparison with previous work. 
(iii) Homogenize. Reduce cellular heterogeneity by maximizing 
cell-type purity, reducing cell numbers studies and comparing 
cells in the same cell cycle stages. For single-cell studies, provide 
one replicate of bulk cells and sufficient numbers of single cells 
to allow merging of libraries to compare single-cell results with 
bulk population experiments. (iv) Validate data orthogonally. For 
instance, Hi-C data may be validated by using DNA FISH or by 
Data
Use
Homogenize
input
Gold
standards
Models/software
Produce
Self-consistent
input
Models of
biological relevance
Deposit
Experiments Computation
Use standards
Cross-validation
Open software
Analyze
Establish databases
Fig. 1 | Toward FAiR data, unified standards and RiCH visualizations in 
4D nucleome research. Experiments and computation need to follow 
good practice guidelines for depositing, using, validating and analyzing 
standardized data sets.
Table 1 | Challenges in producing, analyzing, storing and 
disseminating experimental data and models for the 4D 
nucleome field
Experimental data 3D–4D modeling 
methods
Deposited models
▓ • Standard 
compliance. 
▓ • Accessible and 
traceable. 
▓ • Incorporate 
metadata (e.g., 
experimental set-
ups). 
▓ • Should be self-
consistent. 
▓ • Synthetic 
data for validation 
mimicking controlled 
experiments 
are needed for 
validation.
▓ • Standard 
compliance. 
▓ • Clear definition 
of the basic physical 
assumptions. 
▓ • Benchmarked. 
▓ • Reliability metrics 
▓ • Stable, traceable 
and accessible. 
▓ • Flexibility to 
adapt to different 
experimental set-ups. 
▓ • Cross-validate 
results with data not 
used in the refinement. 
▓ • Compare results 
with random models.
▓ • Standard 
compliance. 
▓ • Accessible and 
traceable. 
▓ • Sustainable 
extension model 
to avoid missed 
information. 
▓ • Incorporate 
metadata on the 
experimental and 
modeling parts. 
▓ • Should be 
ready for RICH 
visualizations 
and integrated in 
multiresolution 
browsers for 
functional 
annotations.
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other genomic approaches such as GAM. Likewise, in vivo imag-
ing using GFP fusion derivatives can be validated by FISH and/or 
IF with appropriate antibodies. Finally, different super-resolution 
microscopy technologies should be compared to cross-validate a 
portion of the results of any given series of new experiments. In 
addition, data predictions made by chromatin contact data may be 
validated by other methods, such as DamID, or by testing inter-
actions of chromatin associated proteins with techniques such as 
FRET or BiFC. These validations can be used to set up or improve 
modeling approaches. (v) Use open software. Analyze the data by 
using publicly available pipelines with software code available in 
full. When developing new analytical approaches, both for genom-
ics and for imaging technologies, benchmark new software when 
possible and make the code publicly and freely available to the 
community. (vi) Set with gold-standards. Standard samples could 
be agreed upon by the community so that groups adopting a new 
technique or developing novel methods can have a benchmark to 
validate and compare their new approaches. This will be key to 
ensure reproducibility and for validating the real advantages of new 
methods compared to established ones. (vii) Establish resources 
databases. The field would considerably profit from the establish-
ment of resources where genomic and microscopy data can be 
deposited, which would encourage cross validation from other 
scientists of primary results, allow proper benchmarking of new 
analysis methods or pipelines and encourage the use of machine 
learning or other emerging technologies to combine data from dif-
ferent sources to unveil novel mechanisms.
Likewise, researchers could consider the following points when 
developing tools for modeling117: (i) Comply with standards. 
Develop software that are properly benchmarked and provide mea-
sures of reliability. (ii) Self-consistent input. Be certain that the data 
used for modeling is self-consistent and does not result a significant 
portion of contradictory models. (iii) Produce models of biologi-
cal relevance. The resulting models shall reflect the native dynamics 
of the genome and provide predictable and experimentally testable 
hypotheses. (iv) Capture variability. Ensure that the models agree 
with the assumptions of one or multiple states observed by experi-
ments. (v) Cross-validate. Compare the models with experimental 
data sets not used during modeling (e.g., imaging data compared 
to 3C-based data). (vi) Analyze the models. Generate models for 
RICH visualization118 to analyze them for additional nonrandom 
patterns that were not evident from used experimental data.
The time is ripe for the 4D nucleome community to discuss stan-
dards for the validation, deposition and analysis of data, as well as 
the resulting models needed for studying the spatiotemporal organi-
zation of the nucleus. Such criteria and standards could be inspired 
by the previous work that the structural biology community has 
carried out over the past decades for storing, disseminating, and 
visualizing data sets and models of proteins, nucleic acids and com-
plex assemblies at different resolutions. To define these standards, 
we would like to propose that current initiatives in the 4D nucleome 
field collect recommendations by data producers and users, develop 
a consensus on validation protocols and identify software applica-
tions to perform such validation tasks. International experts in the 
4D nucleome from experimental and computational fields, as well 
as visualization and data archiving, should meet to address a series 
of open questions that would bring this emerging field significantly 
closer to the desired standards. Finally, 4D nucleome research is 
young and booming. It can be predicted that data types and formats, 
as well as modeling procedures and capacities will evolve signifi-
cantly in the coming years. It will therefore be important to evolve 
data and analytical standards correspondingly and ensure that old 
data, and not only the conclusions derived from them, will be ‘lifted 
over to the newly defined standards to continue to be usable in the 
future, such that 4D nucleome knowledge will continue to increase 
without losing its history.
URLs. NIH-4DNucleome https://commonfund.nih.gov/ 
4dnucleome/index; EU-4DNucleome, http://www.4dnucleome.eu; 
Japan-4DNucleome: https://doi.org/10.1080/19491034.2015.1022
703; MuG, https://www.multiscalegenomics.eu; LifeTime, https://
lifetime-fetflagship.eu
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